Five Oceans Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Five Oceans Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$187K	Hold	11,648	–	–	0.06%	202
2026 Q1	$216K	Hold	11,648	–	–	0.08%	174
2025 Q4	$182K	Sell	11,648 -873	-7%	-$12.5K	0.06%	189
2025 Q3	$183K	Hold	12,521	–	–	0.07%	183
2025 Q2	$194K	Buy	12,521 +241	+2%	+$3.56K	0.08%	183
2025 Q1	$183K	Sell	12,280 -6,222	-34%	-$87.2K	0.09%	171
2024 Q4	$245K	Buy	18,502 +3,364	+22%	+$46.2K	0.11%	131
2024 Q3	$215K	Hold	15,138	–	–	0.1%	173
2024 Q2	$196K	Sell	15,138 -582	-4%	-$7.71K	0.1%	166
2024 Q1	$218K	Hold	15,720	–	–	0.11%	170
2023 Q4	$224K	Sell	15,720 -2,708	-15%	-$38.4K	0.13%	147
2023 Q3	$285K	Sell	18,428 -2,075	-10%	-$32.1K	0.18%	100
2023 Q2	$322K	Hold	20,503	–	–	0.21%	91
2023 Q1	$338K	Hold	20,503	–	–	0.22%	94
2022 Q4	$320K	Hold	20,503	–	–	0.22%	95
2022 Q3	$266K	Buy	20,503 +5,799	+39%	+$80.6K	0.21%	97
2022 Q2	$206K	Buy	14,704 +2,120	+17%	+$30.3K	0.15%	114
2022 Q1	$180K	Buy	+12,584	New	+$185K	0.16%	113

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Five Oceans Advisors's TAK Position: Q2 2026 in Review

Five Oceans Advisors held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 11,648 shares worth $187K. The position accounts for 0.06% of the portfolio, ranked #202.

Five Oceans Advisors first reported a position in TAK in Q1 2022 and has held it in 18 quarters since. The position peaked at $338K in Q1 2023. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Five Oceans Advisors held 11,648 shares of Takeda Pharmaceutical worth $187K as of Q2 2026.
Five Oceans Advisors left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up 0.06% of Five Oceans Advisors's portfolio in Q2 2026, its #202 holding.
Five Oceans Advisors first reported a position in Takeda Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
Five Oceans Advisors's Takeda Pharmaceutical position peaked at $338K in Q1 2023.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.